Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Jason M Kendall a Emergency
Department, Frenchay Hospital, Bristol BS16 1LE, b Clinical Effectiveness Unit, Royal
College of Surgeons of England, London WC2A 3PN, c University College London Clinical
Research Network, Royal Free Hospital, London NW3 2QG
Correspondence to: J M Kendall frenchayed{at}cableinet.co.uk
Objective:
To compare the effectiveness of nasal
diamorphine spray with intramuscular morphine for analgesia in children
and teenagers with acute pain due to a clinical fracture, and to
describe the safety profile of the spray.
Design:
Multicentre randomised controlled trial.
Setting:
Emergency departments
in eight UK hospitals.
Participants:
Patients aged between 3 and 16 years
presenting with a clinical fracture of an upper or lower limb.
Main outcome measures:
Patients' reported pain using
the Wong Baker face pain scale, ratings of reaction to treatment of the
patients and acceptability of treatment by staff and parents, and
adverse events.
Results:
404 eligible patients completed the trial (204 patients given nasal diamorphine spray and 200 given intramuscular morphine). Onset of pain relief was faster in the spray group than in
the intramuscular group, with lower pain scores in the spray group at
5, 10, and 20 minutes after treatment but no difference between the
groups after 30 minutes. 80% of patients given the spray showed no
obvious discomfort compared with 9% given intramuscular morphine
(difference 71%, 95% confidence interval 65% to 78%). Treatment
administration was judged acceptable by staff and parents, respectively, for 98% (199 of 203) and 97% (186 of 192) of patients in the spray group compared with 32% (64 of 199) and 72% (142 of 197)
in the intramuscular group. No serious adverse events occurred in the
spray group, and the frequencies of all adverse events were similar in
both groups (spray 24.1% v intramuscular morphine 18.5%;
difference 5.6%, -2.3% to 13.6%).
Conclusion:
Nasal diamorphine spray should be the
preferred method of pain relief in children and teenagers presenting to emergency departments in acute pain with clinical fractures. The diamorphine spray should be used in place of intramuscular morphine.
Read all Rapid Responses